UNSPSC 42295517: Cardiovascular extenders

In this classification, this commodity indicates a product used as a cardiovascular extender in a medical setting. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42295517 Cardiovascular extenders (Commodity) shows mismatch between the code's nominal scope and recent state and local solicitation activity. The three recent opportunities posted under this code span law enforcement equipment (Sourcewell cooperative), cardiac rhythm management implants (University Medical Center of El Paso), and spinal implants (University of Texas Health Science Center at San Antonio) — only the CRM procurement directly aligns with cardiovascular devices. State and local healthcare systems are the primary buyers in the relevant subset, specifically public teaching hospitals and university health systems establishing multi-vendor frameworks or bill-only contracts for implantable cardiac and spinal devices with strict FDA approval and clinical outcome requirements.

Recent activity concentrates in Texas and the Pacific Northwest. The University Medical Center of El Paso issued RFP 784-03-26-001 for dual-vendor pacemakers, implantable cardioverter-defibrillators, cardiac resynchronization therapy devices, and leadless pacemakers with responses due April 29, 2026, at 2:00 p.m. Mountain Time via Bonfire. The University of Texas Health Science Center at San Antonio posted RFP 745-26-P04 for spinal implants (excluding kyphoplasty and vertebroplasty) with a proposal deadline of March 10, 2026, requiring HUB Subcontracting Plans and bill-only delivery within 24 hours. Sourcewell, a Minnesota cooperative, issued RFP 061626 for law enforcement equipment available to thousands of public entities with responses due June 16, 2026, but this procurement is unrelated to the cardiovascular code. The code shows limited relevant activity; pursuit should focus on the two medical-device opportunities in Texas where hospital systems are actively seeking qualified vendors for implantable devices under multi-year frameworks.